Related Experiment Videos
Adoptive immunotherapy of urologic tumors
Cancer Treatment and Research
|January 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Interferon Alpha, GM-CSF-Activated T Cells, and IL-6 in Renal Cell Carcinoma.
Methods in molecular medicine·2011
Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis.
British journal of cancer·2006
Synchronous RCC and TCC of the Kidney in a Patient With Multiple Recurrent Bladder Tumors.
Reviews in urology·2006
Nephron-sparing surgery for renal cell carcinoma.
Reviews in urology·2006
Immune and genetic therapies for advanced renal cell carcinoma.
Reviews in urology·2006
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026
Regulatory T cells in intracerebral hemorrhage: mechanisms of immunomodulation and therapeutic potential.
Frontiers in immunology·2026
Fc-engineering for improved cancer immunotherapy.
Biochemical Society transactions·2026
Explosive Multiterritorial Arterial Thrombosis Following Brief Heparin Exposure: A Diagnostic Pitfall in the Cath Lab.
Case reports in cardiology·2026
Lipophilic Ligand Efficiency-Monitored Discovery of Potent, Achiral, and Bioavailable Apo-IDO1 Inhibitors.
ACS medicinal chemistry letters·2026
Telitacicept for IgA nephropathy: a systematic review and meta-analysis of observational studies.
Frontiers in medicine·2026
Envafolimab - novel anti-PD-1/PD-L1 antibody in cancer treatment.
Frontiers in immunology·2026